{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:26Z","timestamp":1790790326437,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2022AH050533"],"award-info":[{"award-number":["2022AH050533"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2024AH051036"],"award-info":[{"award-number":["2024AH051036"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304853"],"award-info":[{"award-number":["82304853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.mtbio.2024.101441","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T02:17:26Z","timestamp":1735697846000},"page":"101441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment"],"prefix":"10.1016","volume":"30","author":[{"given":"Nuo","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7825-9596","authenticated-orcid":false,"given":"Yunna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101441_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu Rev Pathol-Mech"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2024.101441_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115545","article-title":"Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies","volume":"212","author":"Karim","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101441_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/14737140.2024.2341729","article-title":"Current usage of pembrolizumab in triple negative breast cancer (TNBC)","volume":"24","author":"O'Rourke","year":"2024","journal-title":"Expert Rev Anticanc"},{"issue":"6","key":"10.1016\/j.mtbio.2024.101441_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13543784.2022.2049232","article-title":"Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer","volume":"31","author":"Agostinetto","year":"2022","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mtbio.2024.101441_bib7","first-page":"1449","article-title":"Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment","volume":"130","author":"Wu","year":"2024","journal-title":"Cancer-Am Cancer Soc"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101441_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020369","article-title":"Breaking barriers: the promise and challenges of immune checkpoint inhibitors in triple-negative breast cancer","volume":"12","author":"Said","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101441_bib9","article-title":"Advancing precision oncology: insights into the tumor microenvironment and immunotherapy outcomes","volume":"5","author":"Ugai","year":"2024","journal-title":"Innovation"},{"issue":"6","key":"10.1016\/j.mtbio.2024.101441_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay7785","article-title":"Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-\u03baB inhibitor for antitumor immunotherapy","volume":"6","author":"Xiao","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2024.101441_bib11","first-page":"57","article-title":"Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation","volume":"21","author":"Xiao","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2024.101441_bib12","volume":"vol. 44","author":"Xiao","year":"2022"},{"issue":"16","key":"10.1016\/j.mtbio.2024.101441_bib13","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-18-3524","article-title":"Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer","volume":"25","author":"Xiao","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101441_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/cac2.12546","article-title":"Converting \"cold\" to \"hot\": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells","volume":"44","author":"Tang","year":"2024","journal-title":"Cancer Commun."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101441_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101441_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","article-title":"Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy","volume":"43","author":"Guo","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010211","article-title":"Cancer-associated fibroblasts: major co-conspirators in tumor development","volume":"16","author":"Singh","year":"2024","journal-title":"Cancers"},{"issue":"28","key":"10.1016\/j.mtbio.2024.101441_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401269","article-title":"Hydrogen therapy reverses cancer-associated fibroblasts phenotypes and remodels stromal microenvironment to stimulate systematic anti-tumor immunity","volume":"11","author":"Meng","year":"2024","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101441_bib19","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.7150\/thno.68972","article-title":"FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101441_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101441_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/2326-6066.CIR-22-0593","article-title":"T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profile","volume":"11","author":"Yan","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"7693","key":"10.1016\/j.mtbio.2024.101441_bib22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101441_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2144669","article-title":"Chemokine switch regulated by TGF-\u03b21 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy","volume":"11","author":"Vienot","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.mtbio.2024.101441_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122253","article-title":"Synchronous targeted delivery of TGF-\u00df siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment","volume":"301","author":"Yang","year":"2023","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.mtbio.2024.101441_bib26","doi-asserted-by":"crossref","first-page":"E957","DOI":"10.1073\/pnas.1420419112","article-title":"Dendritic cell SIRT1-HIF1\u03b1 axis programs the differentiation of CD4+ T cells through IL-12 and TGF-\u03b21","volume":"112","author":"Liu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101441_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3892\/or.2012.1822","article-title":"TGF-\u03b2 of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation","volume":"28","author":"Ni","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mtbio.2024.101441_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103029","article-title":"Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis","volume":"69","author":"Fu","year":"2024","journal-title":"Redox Biol."},{"issue":"27","key":"10.1016\/j.mtbio.2024.101441_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202314309","article-title":"A comprehensive strategy based on high clinical translational nanosystem for programmable immunotherapy of triple negative breast cancer","volume":"36","author":"Meng","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.mtbio.2024.101441_bib30","article-title":"Nano-delivery of salvianolic acid B induces the quiescence of tumor-associated fibroblasts via interfering with TGF-\u03b21\/Smad signaling to facilitate chemo- and immunotherapy in desmoplastic tumor","volume":"623","author":"Chen","year":"2022","journal-title":"Int. J. Pharm. (Amst.)"},{"key":"10.1016\/j.mtbio.2024.101441_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106333","article-title":"Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy","volume":"182","author":"Qian","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"13","key":"10.1016\/j.mtbio.2024.101441_bib32","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2174\/1389201024666230313151316","article-title":"Nanoparticle delivery of active traditional Chinese medicine ingredients: a new strategy for the treatment of liver cancer","volume":"24","author":"Wang","year":"2023","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.mtbio.2024.101441_bib33","doi-asserted-by":"crossref","DOI":"10.1039\/D2TB00225F","article-title":"Nano-traditional Chinese medicine: a promising strategy and its recent advances","author":"Wei","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2024.101441_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116330","article-title":"Traditional Chinese medicine polysaccharide in nano-drug delivery systems: current progress and future perspectives","volume":"173","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2024.101441_bib35","article-title":"Nanotechnology-enhanced immunotherapy for metastatic cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"Innovation"},{"issue":"9","key":"10.1016\/j.mtbio.2024.101441_bib36","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.apsb.2024.05.032","article-title":"Enhancing cancer immunotherapy: nanotechnology-mediated immunotherapy overcoming immunosuppression","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2024.101441_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jconrel.2023.02.029","article-title":"Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy","volume":"356","author":"Xiao","year":"2023","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01852-x","article-title":"Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"48","key":"10.1016\/j.mtbio.2024.101441_bib39","doi-asserted-by":"crossref","first-page":"56825","DOI":"10.1021\/acsami.1c12406","article-title":"Macrophage-mediated porous magnetic nanoparticles for multimodal imaging and postoperative photothermal therapy of gliomas","volume":"13","author":"Wang","year":"2021","journal-title":"Acs Appl Mater Inter"},{"issue":"6","key":"10.1016\/j.mtbio.2024.101441_bib40","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1166\/jnn.2021.19017","article-title":"Capturing of magnetic nanoparticles in a fluidic channel for magnetic drug targeting","volume":"21","author":"Sharma","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"9","key":"10.1016\/j.mtbio.2024.101441_bib41","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1039\/D1BM01963E","article-title":"Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era","volume":"10","author":"Pucci","year":"2022","journal-title":"Biomater Sci-Uk"},{"issue":"22","key":"10.1016\/j.mtbio.2024.101441_bib42","doi-asserted-by":"crossref","first-page":"14469","DOI":"10.1021\/acsnano.4c01253","article-title":"Multiple synergistic effects of the microglia membrane-bionic nanoplatform on mediate tumor microenvironment remodeling to amplify glioblastoma immunotherapy","volume":"18","author":"Fan","year":"2024","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101441_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040531","article-title":"Cell membrane-coated biomimetic nanoparticles in cancer treatment","volume":"16","author":"Zhang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101441_bib44","article-title":"Red blood cell membrane-camouflaged gold-core silica shell nanorods for cancer drug delivery and photothermal therapy","volume":"655","author":"Rodrigues","year":"2024","journal-title":"Int. J. Pharm. (Amst.)"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/02656736.2018.1536809","article-title":"A, Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition","volume":"36","author":"Dabbagh","year":"2019","journal-title":"Int. J. Hyperther."},{"issue":"37","key":"10.1016\/j.mtbio.2024.101441_bib47","doi-asserted-by":"crossref","first-page":"49003","DOI":"10.1021\/acsami.4c08602","article-title":"Precision treatment of colon cancer using doxorubicin-loaded metal-organic-framework-coated magnetic nanoparticles","volume":"16","author":"Jiang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2024.101441_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actbio.2022.05.045","article-title":"Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy","volume":"148","author":"Zang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2024.101441_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2021.09.034","article-title":"Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo\/photothermal therapy of cervical cancer and anti-inflammation","volume":"339","author":"Xiao","year":"2021","journal-title":"J. Contr. Release"},{"issue":"51","key":"10.1016\/j.mtbio.2024.101441_bib50","doi-asserted-by":"crossref","first-page":"59117","DOI":"10.1021\/acsami.3c12560","article-title":"Intelligent nanoplatform integrating macrophage and cancer cell membrane for synergistic chemodynamic\/immunotherapy\/photothermal therapy of breast cancer","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.mtbio.2024.101441_bib51","doi-asserted-by":"crossref","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","article-title":"Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer","volume":"15","author":"Xiong","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101441_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-01085-y","article-title":"Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101441_bib53","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"Cellular Physiology"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101441_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","article-title":"Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T cells","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424005027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424005027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:29:32Z","timestamp":1762633772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006424005027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":54,"alternative-id":["S2590006424005027"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101441","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101441"}}